Biomatter
Synthetic biology company that creates new proteins for health and sustainable manufacturing applications
Biomatter has raised €6.5M across 1 funding round from 5 investors, most recently a Seed round in Aug 2024. Based in Vilnius, Lithuania; active in Healthtech. Data as of 28 Oct 2026.
Vilnius, Lithuaniabiomatter.ai ↗
Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-08
latest 2024-08
Funding by year
EUR raised per yearBiomatter — funding by year — interactive chart.
Data table
| Biomatter — funding by year | |
|---|---|
| 2024 | €6.5M |
Signals
High confidenceRaise-next likelihood19
base rate 44% for Seed
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-08-06 | Seed | €6.5M | Business Angels,Inventure,Metaplanet,Practica Capital,UVC Partners | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Vinted€817MLithuania · Fashion
Global coverage: FundingData